Beryl Drugs Share Price
24.99+1.15 (+4.82%)
+3.69% past 1 Year
Beryl Drugs Limited is incorporated on August 24, 1993 under the provisions of The Companies Act, 1956. The company is engaged in the sole segment of pharmaceuticals manufacturing. The company
Corporate filings & documents
Announcements
ANNUAL REPORT 2025-2026
21 hours agoANNUAL REPORT 2025-2026
21 hours ago33RD ANNUAL GENERAL MEETING NOTICE
23 hours ago33RD ANNUAL GENERAL MEETING NOTICE
23 hours agoEVOTING DATES FOR THE PURPOSE OF 33RD ANNUAL GENERAL MEETING
1 day agoRECORD DATE
1 day agoINTIMATION OF ANNUAL BOOK CLOSURE
1 day agoOUTCOME OF BOARD MEETING
1 day agoOUTCOME OF BOARD MEETING
1 day agoBeryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 inter alia to consider and approve approve board report and other matters related to 33rd annual general meeting of the company
1 week agoBeryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 inter alia to consider and approve approve board report and other matters related to 33rd annual general meeting of the company
1 week agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
2 weeks agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
2 weeks agoNEWSPAPER PUBLICATION OF UNAUDITED QUARTERLY FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2026
3 weeks agoNEWSPAPER PUBLICATION OF UNAUDITED QUARTERLY FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2026
3 weeks agoUNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2026
3 weeks agoUNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2026
3 weeks agoOUTCOME OF BOARD MEETING
3 weeks agoOUTCOME OF BOARD MEETING
3 weeks agoBeryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the unaudited financial results for the quarter ended 30th june 2026
1 month agoBeryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the unaudited financial results for the quarter ended 30th june 2026
1 month agoTEMPORARY UNAVAILABILITY OF THE COMPANYS WEBSITE "www.beryldrugs.com" DUE TO AN UNEXPECTED TECHNICAL ISSUE.
1 month agoTEMPORARY UNAVAILABILITY OF THE COMPANYS WEBSITE "www.beryldrugs.com" DUE TO AN UNEXPECTED TECHNICAL ISSUE.
1 month agoCERTIFICATE UNDER REGULATION 74(5) OF SEBI (DP) REGULATIONS 2018
1 month agoCERTIFICATE UNDER REGULATION 74(5) OF SEBI (DP) REGULATIONS 2018
1 month agoNON-APPLOCABILITY CERTIFICATE UNDER REGULATION 57(5) FOR THE QUARTER ENDED 30TH JUNE 2026
1 month agoNON-APPLOCABILITY CERTIFICATE UNDER REGULATION 57(5) FOR THE QUARTER ENDED 30TH JUNE 2026
1 month agoCLOSURE OF TRADING WINDOW FOR THE QUARTER ENDED 30.06.2026
2 months agoCLOSURE OF TRADING WINDOW FOR THE QUARTER ENDED 30.06.2026
2 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
2 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
2 months agoCHANGE IN REGISTERED OFFICE OF THE COMPANY FROM 133 KANCHAN BAGH INDORE TO 29 NEER NAGAR MAYANK WATER PARK ROAD BICHOLI INDORE WITHIN LOCAL LIMITS OF SAME CITY
2 months agoCHANGE IN REGISTERED OFFICE OF THE COMPANY FROM 133 KANCHAN BAGH INDORE TO 29 NEER NAGAR MAYANK WATER PARK ROAD BICHOLI INDORE WITHIN LOCAL LIMITS OF SAME CITY
2 months agoOUTCOME OF BOARD MEETING
2 months agoOUTCOME OF BOARD MEETING
2 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
2 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
2 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
2 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
2 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
2 months agoBeryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/06/2026 inter alia to consider and approve change in registered office of the company within local limits of the same city
2 months agoBeryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/06/2026 inter alia to consider and approve change in registered office of the company within local limits of the same city
2 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
2 months agoNEWSPAPER PUBLICATION OF AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31ST MARCH 2026
3 months agoNEWSPAPER PUBLICATION OF AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31ST MARCH 2026
3 months agoAUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31ST MARCH 2026
3 months agoOUTCOME OF BOARD MEETING
3 months agoBeryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 inter alia to consider and approve consider and approve the Audited Financial Statement including Balance Sheet as at 31st March 2026 Statement of Profit and Loss Cash Flow and Notes thereon for the year ended 31st March 2026.
3 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
29, Neer Nagar Mayank Water Park Road Bicholi Indore Madhya Pradesh PIN: 452016 Tel No: 0731-2517677 Fax No: 0731-2517677 Email: [email protected] Internet: www.beryldrugs.com
Registrars
19 Jaferbhoy Industrial Estate , 1st Floor,Makwana Road,Marol Naka,Mumbai 19, Jaferbhoy Industrial Estate Makwana Road, Marol Naka Andheri (E) PIN: Tel No: 022-28590942/3748 Fax No: 022-56924438 Email: NULL
Management
Sanjay Sethi, Managing Director
Sudhir Sethi, Chairman
Abhinav Naik, Non Executive Independent Director
Shreya Saraf, Non Executive Independent Women Director
Kamlesh Gupta, Company Secretary
Shailendra Pathak, Whole Time Director
Neha Sarda, Independent Director
Details
BSE 524606
NSE NULL
ISIN INE415H01017